The Effect of Lnterleukin-6 Gene Polymorphism on Pediatric Pneumonia

Overview

Journal Iran J Public Health

Date 2020 Jan 24

PMID 31970102

Citations 1

Authors

Guode Su

Lili Ding

Zhenkun Zhang

Affiliations

Soon will be listed here.

Abstract

Background: To investigate the effect of interleukin-6 (IL-6) gene polymorphism on pediatric pneumonia.

Methods: Overall, 438 patients with pediatric pneumonia (Observation group) treated in Xuzhou Children Hospital, Cinna from July 2013 to July 2018 were randomly enrolled. Meanwhile, 423 healthy children (Control group) in the same time period were randomly selected. PCR was applied to amplify the IL-6-572 gene fragment. The IL-6-572 polymorphism was detected, and the impacts of gene polymorphism difference on pediatric pneumonia were observed.

Results: There were differences in the IL-6 genotypes between the two groups (<0.05). Among the CG+GG genotypes in Observation group, G allele frequency was higher than that in control group (<0.05). The risk of pediatric pneumonia for GC genotype was 2.13 times as high as that for CC genotype, and the risk of pediatric pneumonia for GG genotype was 5.56 times as high as that for CC genotype.

Conclusion: IL-6 gene polymorphism might be related to the pediatric pneumonia and the population with G allele at this locus may be more prone to pediatric pneumonia.

Citing Articles

Association between HMGCR, CRP, and CETP gene polymorphisms and metabolic/inflammatory serum profile in healthy adolescents.

Perrone B, Ruffo P, Augimeri G, Sisci D, Sinicropi M, Tripepi G J Transl Med. 2023; 21(1):718.

PMID: 37833739 PMC: 10576320. DOI: 10.1186/s12967-023-04571-z.

References

Philips C, Sarin S . Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol. 2014; 20(43):16037-52. PMC: 4239490. DOI: 10.3748/wjg.v20.i43.16037. View

Bradley J, Byington C, Shah S, Alverson B, Carter E, Harrison C . Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011; 53(7):617-30. PMC: 3202323. DOI: 10.1093/cid/cir625. View

Rossi J, Lu Z, Jourdan M, Klein B . Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015; 21(6):1248-57. DOI: 10.1158/1078-0432.CCR-14-2291. View

Alcoba G, Manzano S, Lacroix L, Galetto-Lacour A, Gervaix A . Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy study. BMC Infect Dis. 2015; 15:347. PMC: 4543464. DOI: 10.1186/s12879-015-1095-5. View

Tartter M, Hammen C, Bower J, Brennan P, Cole S . Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth. Brain Behav Immun. 2015; 46:104-11. PMC: 4515110. DOI: 10.1016/j.bbi.2015.01.003. View

OReilly S, Cant R, Ciechomska M, van Laar J . Interleukin-6: a new therapeutic target in systemic sclerosis?. Clin Transl Immunology. 2014; 2(4):e4. PMC: 4232056. DOI: 10.1038/cti.2013.2. View

Self W, Grijalva C, Zhu Y, McNaughton C, Barrett T, Collins S . Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009. Acad Emerg Med. 2013; 20(9):957-60. PMC: 3907184. DOI: 10.1111/acem.12203. View

Zidan H, Elbehedy R, Azab S . IL6-174 G/C gene polymorphism and its relation to serum IL6 in Egyptian children with community-acquired pneumonia. Cytokine. 2014; 67(2):60-4. DOI: 10.1016/j.cyto.2014.02.013. View

Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

10.

Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D . Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012; 166(12):1155-64. DOI: 10.1001/archpediatrics.2012.1266. View

11.

Chou S, Ko H, Lin Y . CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia. Genet Test Mol Biomarkers. 2016; 20(12):732-740. DOI: 10.1089/gtmb.2016.0156. View

12.

Lauderdale T, Chang F, Ben R, Yin H, Ni Y, Tsai J . Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med. 2005; 99(9):1079-86. DOI: 10.1016/j.rmed.2005.02.026. View

13.

Griffin M, Zhu Y, Moore M, Whitney C, Grijalva C . U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013; 369(2):155-63. PMC: 4877190. DOI: 10.1056/NEJMoa1209165. View

14.

Levine O, OBrien K, Deloria-Knoll M, Murdoch D, Feikin D, DeLuca A . The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis. 2012; 54 Suppl 2:S93-101. PMC: 3297546. DOI: 10.1093/cid/cir1052. View

15.

Leng S, Thomas C, Snider A, Picchi M, Chen W, Willis D . Radon Exposure, IL-6 Promoter Variants, and Lung Squamous Cell Carcinoma in Former Uranium Miners. Environ Health Perspect. 2015; 124(4):445-51. PMC: 4829998. DOI: 10.1289/ehp.1409437. View

16.

Andrijevic I, Matijasevic J, Andrijevic L, Kovacevic T, Zaric B . Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia. Ann Thorac Med. 2014; 9(3):162-7. PMC: 4073574. DOI: 10.4103/1817-1737.134072. View

17.

Hunter C, Jones S . IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015; 16(5):448-57. DOI: 10.1038/ni.3153. View

18.

Kang S, Tanaka T, Kishimoto T . Therapeutic uses of anti-interleukin-6 receptor antibody. Int Immunol. 2014; 27(1):21-9. DOI: 10.1093/intimm/dxu081. View

19.

Garcia-Garcia M, Calvo C, Pozo F, Villadangos P, Perez-Brena P, Casas I . Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J. 2012; 31(8):808-13. DOI: 10.1097/INF.0b013e3182568c67. View

20.

Jia W, Fei G, Hu J, Hu X . A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer. Onco Targets Ther. 2015; 8:2699-704. PMC: 4590668. DOI: 10.2147/OTT.S84636. View